Since its launch in 2025, more than one million users have adopted the Ottai CGM.
StockStory.org on MSN
Unpacking Q4 earnings: ResMed (NYSE:RMD) in the context of other patient monitoring stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
Ascension drives quality access by using digital nudges to boost screenings, chronic care, and medication adherence across its health system.
HSIC's growth from its Henry Schein One venture and partnerships is promising, but macro pressures and stiff competition ...
In this conversation, Ashissh Raichura unpacks why point-of-care diagnostics must evolve beyond fragmented devices into ...
With thousands of companies and a $102 billion impact on the state’s economy, Indiana’s life sciences industry is making its ...
Most diabetes patients must carefully monitor their blood sugar levels and inject insulin multiple times per day, to help ...
The world of healthcare is always changing, and keeping up can feel like a full-time job. From how we pay for care to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results